UNSPSC 41202054: Rubella virus serological reagents

In this classification, Rubella virus serological reagents are devices used in test to identify specific Rubella virus antibodies in serum. US FDA regulates Rubella virus serological reagents under 21 CFR 866.3510 and under FDA product code GON.

UNSPSC 41202054 Rubella virus serological reagents is a Commodity code that in practice covers a much broader range of infectious-disease serological testing supplies and reagents than the code name suggests — state and local health departments and criminal-justice agencies are currently soliciting HIV, syphilis, gonorrhea/chlamydia, and drug-testing reagents and analyzer consumables under this classification, often bundled with lab certification, electronic reporting, quality control, and equipment-maintenance services. Illinois Department of Public Health, the City of Austin, Collin County (Texas) Health Care Services and Community Supervision and Corrections Department, Gwinnett County (Georgia), and the Texas Department of Criminal Justice have all posted opportunities under or closely related to this code in recent months. The scope extends from simple test-kit procurement (rapid HIV kits from Abbott) to comprehensive reagent supplies for complex analyzer platforms (Hologic NAAT systems for STI testing, Abbott ARCHITECT systems for HIV and syphilis screening) to full-service laboratory operations including specimen collection, testing, electronic reporting, and performance standards compliance with CLIA, HIPAA, and state lab-certification requirements. Illinois and Texas dominate recent activity, with secondary activity in Georgia.

Recent representative opportunities include the Illinois Department of Public Health change order (27482DPHOFCDIB53956, IFB, due October 13, 2026) increasing annual NG/CT testing from 15,000 to 25,000 tests and collection kits from 15,000 to 30,000 under a Hologic reagent rental agreement, raising the contract cost from $525,000 to $900,000 over five years; the City of Austin rapid HIV test-kit procurement (IFB 9100 AAM1023 REBID, due September 3, 2026) for approximately 375 Abbott Determine test kits and 79 control kits annually; and Collin County Community Supervision and Corrections Department's offender drug-testing RFP (2026-327, due July 23, 2026) valued at $600,000 for approximately 25,031 annual tests (immunoassay screening with LC/MS/MS or GC/MS confirmation) across two collection sites with lab certification from SAMHSA, Texas DPS, or CAP. The Illinois Department of Public Health has also conducted emergency sole-source procurements for Abbott HIV and syphilis reagents ($38,079.50, May 2026 execution) for critical public health operations at the Carbondale Laboratory, indicating that proprietary equipment lock-in and supply-chain continuity drive significant procurement activity outside competitive bidding.